2017 saw a spike in investor confidence and complacency, as volatility fell significantly and appetite for risk fueled many stocks higher. Chad Morganlander, Portfolio Manager at Washington Crossing Advisors, was with us to discuss whether he expects more of the same for the year ahead. Morganlander says we are at point in the market cycle where global growth is predictable in the short-term. His firm is somewhat optimistic, but aware that valuations are becoming quite stretched, he adds. Morganlander believes markets are entering a period of low growth for next several years, predicting a 4% to 6% return in U.S. equities. One of Morganlander's top picks for the year is Hershey’s. He suggests investors stick with "big and boring" companies. With Hershey's, investors can go to sleep for 3-5 years and wake up with tremendous returns, according to Morganlander. Hershey's has also entered a bid for Nestle's U.S. confectionary business, which includes brands such as Butterfunger and Baby Ruth. The potential acquisition is not baked in to Washington Crossing Advisor's outlook. He also recommends shares of Hormel Foods and Dr Pepper Snapple.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More